Forepont is raising US$200 million and has secured US$ 130 million so far. The GP is supported by a number of well-known Family Offices, institutional investors and senior industry advisers (also LPs).

​

Forepont is dedicated to Neurosearch via it's Neurogen Foundation (neurogen.org). Connected to the industry via an extremely experienced team, Forepont offers strong deal sourcing and ability to assist investee companies from planning of clinical trials, execution, funding, daily management and scaling. 

​

The team has in the past managed the R&D-to-market launch of several Blockbusters. 

​

www.forepont.com